Cargando…
Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
Within past decades, human infections with emerging and reemerging zoonotic viral pathogens have raised the eminent public health concern. Since November 2002, three highly pathogenic and major deadly human coronaviruses of the βετα-genera (β-hCoVs), namely, severe acute respiratory distress syndrom...
Autor principal: | Alsafi, Radi Taha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391183/ https://www.ncbi.nlm.nih.gov/pubmed/35992513 http://dx.doi.org/10.1155/2022/1156273 |
Ejemplares similares
-
SARS-CoV-2 Related Myocarditis: What We Know So Far
por: Mistrulli, Raffaella, et al.
Publicado: (2023) -
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
por: Rabi, Firas A., et al.
Publicado: (2020) -
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
por: Chavda, Vivek P., et al.
Publicado: (2022) -
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?
por: Shaikh, Taha Gul, et al.
Publicado: (2022) -
SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far
por: Biondo, Carmelo, et al.
Publicado: (2022)